Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 4 studies | 38% ± 14% | |
glutamatergic neuron | 4 studies | 39% ± 15% | |
endothelial cell | 3 studies | 23% ± 8% | |
epithelial cell | 3 studies | 24% ± 7% | |
oligodendrocyte precursor cell | 3 studies | 21% ± 5% | |
neuron | 3 studies | 22% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 33% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 627.21 | 359 / 359 | 100% | 17.38 | 285 / 286 |
prostate | 100% | 898.72 | 245 / 245 | 100% | 11.70 | 500 / 502 |
breast | 100% | 714.83 | 459 / 459 | 99% | 16.48 | 1112 / 1118 |
intestine | 100% | 968.89 | 966 / 966 | 99% | 15.06 | 523 / 527 |
lung | 100% | 825.85 | 576 / 578 | 99% | 13.48 | 1142 / 1155 |
esophagus | 100% | 561.61 | 1445 / 1445 | 98% | 19.86 | 180 / 183 |
brain | 100% | 889.28 | 2638 / 2642 | 98% | 8.11 | 688 / 705 |
bladder | 100% | 733.29 | 21 / 21 | 97% | 11.88 | 488 / 504 |
uterus | 100% | 905.86 | 170 / 170 | 97% | 10.42 | 444 / 459 |
pancreas | 100% | 457.26 | 328 / 328 | 97% | 9.64 | 172 / 178 |
ovary | 100% | 730.22 | 180 / 180 | 96% | 9.12 | 412 / 430 |
thymus | 100% | 763.89 | 653 / 653 | 92% | 6.51 | 555 / 605 |
adrenal gland | 100% | 707.54 | 258 / 258 | 89% | 9.21 | 205 / 230 |
skin | 100% | 714.47 | 1809 / 1809 | 88% | 7.99 | 415 / 472 |
kidney | 100% | 605.13 | 89 / 89 | 81% | 5.07 | 731 / 901 |
liver | 92% | 290.19 | 209 / 226 | 78% | 7.12 | 315 / 406 |
adipose | 100% | 652.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 847.26 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.86 | 1 / 1 |
blood vessel | 100% | 539.15 | 1333 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 7.92 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 96% | 7.25 | 43 / 45 |
heart | 91% | 297.21 | 785 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 72% | 770.38 | 668 / 929 | 0% | 0 | 0 / 0 |
muscle | 65% | 131.89 | 521 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 43% | 2.20 | 34 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046620 | Biological process | regulation of organ growth |
GO_0043249 | Biological process | erythrocyte maturation |
GO_0001701 | Biological process | in utero embryonic development |
GO_0055085 | Biological process | transmembrane transport |
GO_0015886 | Biological process | heme transport |
GO_0048704 | Biological process | embryonic skeletal system morphogenesis |
GO_0042733 | Biological process | embryonic digit morphogenesis |
GO_0006839 | Biological process | mitochondrial transport |
GO_0035264 | Biological process | multicellular organism growth |
GO_0006783 | Biological process | heme biosynthetic process |
GO_0048536 | Biological process | spleen development |
GO_0030218 | Biological process | erythrocyte differentiation |
GO_0006879 | Biological process | intracellular iron ion homeostasis |
GO_0001568 | Biological process | blood vessel development |
GO_0097037 | Biological process | heme export |
GO_0060323 | Biological process | head morphogenesis |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0015232 | Molecular function | heme transmembrane transporter activity |
GO_0020037 | Molecular function | heme binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FLVCR1 |
Protein name | FLVCR heme transporter 1 Heme transporter FLVCR1 (Feline leukemia virus subgroup C receptor-related protein 1) (Feline leukemia virus subgroup C receptor) (hFLVCR) |
Synonyms | FLVCR |
Description | FUNCTION: [Isoform 1]: Heme b transporter that mediates heme efflux from the cytoplasm to the extracellular compartment. Heme export depends on the presence of HPX and is required to maintain intracellular free heme balance, protecting cells from heme toxicity. Heme export provides protection from heme or ferrous iron toxicities in liver, brain, sensory neurons and during erythropoiesis, a process in which heme synthesis intensifies. Possibly export coproporphyrin and protoporphyrin IX, which are both intermediate products in the heme biosynthetic pathway. Does not export bilirubin. The molecular mechanism of heme transport, whether electrogenic, electroneutral or coupled to other ions, remains to be elucidated. .; FUNCTION: [Isoform 1]: (Microbial infection) Confers susceptibility to feline leukemia virus subgroup C (FeLV-C) infection in vitro. .; FUNCTION: [Isoform 2]: Heme b transporter that promotes heme efflux from the mitochondrion to the cytoplasm. Essential for erythroid differentiation. . |
Accessions | H7C3Z2 ENST00000419102.1 Q9Y5Y0 ENST00000366971.9 [Q9Y5Y0-1] |